Gilead Sciences (GILD) Interest Expenses (2009 - 2026)

Gilead Sciences (GILD) has reported Interest Expenses for 18 consecutive years, with $240.0 million the latest figure, recorded in Q1 2026.

• Interest Expenses for Q1 2026 came in at $240.0 million, down 7.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 2.13% YoY), and the FY2025 annual result was $1.0 billion, up 4.81% from the prior year.
• Interest Expenses was $240.0 million for Q1 2026 at Gilead Sciences, down from $255.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $260.0 million in Q1 2025 and troughed at $226.0 million in Q4 2022.
• Average Interest Expenses over 5 years is $242.5 million, with a median of $240.0 million recorded in 2026.
• Year-over-year, Interest Expenses declined 8.4% in 2022 and increased 11.5% in 2023.
• Over 5 years, Interest Expenses stood at $226.0 million in 2022, then rose by 11.5% to $252.0 million in 2023, then fell by 1.19% to $249.0 million in 2024, then advanced by 2.41% to $255.0 million in 2025, then fell by 5.88% to $240.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $240.0 million in Q1 2026, $255.0 million in Q4 2025, and $256.0 million in Q3 2025.